Hidehito Matsuoka

Title: Innovations of Hidehito Matsuoka

Introduction

Hidehito Matsuoka is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of pharmacology, particularly in the development of angiogenesis inhibitors. With a total of 2 patents, Matsuoka's work focuses on finding new pharmacological actions of urea compounds.

Latest Patents

Matsuoka's latest patents include a novel angiogenesis inhibitor. The primary objective of this invention is to discover new pharmacological actions of urea compounds characterized by a specific general formula. These urea compounds exhibit excellent angiogenesis inhibitory actions. The invention also outlines a method for inhibiting angiogenesis by administering a pharmaceutically effective amount of the angiogenesis inhibitor to patients in need. This method is particularly relevant for treating diseases where angiogenesis plays a critical role, such as diabetic retinopathy, macular degeneration, and various tumors.

Career Highlights

Matsuoka is currently associated with Santen Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work has the potential to impact the treatment of several serious medical conditions.

Collaborations

Matsuoka has collaborated with notable colleagues, including Kazuo Nishimura and Hisayuki Seike, contributing to advancements in their shared field of expertise.

Conclusion

Hidehito Matsuoka's contributions to the development of angiogenesis inhibitors highlight his role as a significant inventor in the pharmaceutical industry. His innovative work continues to pave the way for new treatments for critical health issues.